OrbiMed’s Syndax Pharmaceuticals SNDX Stock Holding History

OrbiMed’s Portfolio SNDX Stock Details SNDX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,925,300	Closed	-$37.1M	–	128
2024 Q3	$37.1M	Hold	1,925,300	–	–	0.67%	42
2024 Q2	$39.5M	Buy	1,925,300 +176,300	+10%	+$3.62M	0.78%	42
2024 Q1	$41.6M	Hold	1,749,000	–	–	0.76%	44
2023 Q4	$37.8M	Buy	1,749,000 +465,000	+36%	+$10M	0.75%	44
2023 Q3	$18.6M	Sell	1,284,000 -1,246,240	-49%	-$18.1M	0.4%	65
2023 Q2	$53M	Buy	2,530,240 +818,565	+48%	+$17.1M	0.96%	39
2023 Q1	$36.2M	Sell	1,711,675 -294,825	-15%	-$6.23M	0.71%	46
2022 Q4	$51.1M	Hold	2,006,500	–	–	0.98%	39
2022 Q3	$48.2K	Sell	2,006,500 -316,800	-14%	-$7.61K	0.9%	43
2022 Q2	$44.7K	Buy	2,323,300 +165,000	+8%	+$3.18K	0.81%	39
2022 Q1	$37.5M	Buy	2,158,300 +177,000	+9%	+$3.08M	0.61%	47
2021 Q4	$43.4M	Buy	1,981,300 +1,790,700	+940%	+$39.2M	0.56%	52
2021 Q3	$3.64M	Buy	+190,600	New	+$3.64M	0.04%	158
2021 Q1	–	Sell	-1,170,900	Closed	-$26M	–	174
2020 Q4	$26M	Buy	1,170,900 +76,800	+7%	+$1.71M	0.23%	89
2020 Q3	$16.1M	Hold	1,094,100	–	–	0.2%	94
2020 Q2	$16.2M	Buy	1,094,100 +804,100	+277%	+$11.9M	0.23%	84
2020 Q1	$3.18M	Buy	290,000 +78,000	+37%	+$856K	0.05%	115
2019 Q4	$1.86M	Hold	212,000	–	–	0.03%	116
2019 Q3	$1.58M	Hold	212,000	–	–	0.03%	104
2019 Q2	$1.97M	Hold	212,000	–	–	0.03%	113
2019 Q1	$1.11M	Hold	212,000	–	–	0.02%	113
2018 Q4	$943K	Sell	212,000 -225,000	-51%	-$1M	0.02%	118
2018 Q3	$3.53M	Hold	437,000	–	–	0.04%	131
2018 Q2	$3.07M	Hold	437,000	–	–	0.04%	130
2018 Q1	$6.22M	Hold	437,000	–	–	0.08%	113
2017 Q4	$3.83M	Hold	437,000	–	–	0.05%	117
2017 Q3	$5.11M	Hold	437,000	–	–	0.05%	119
2017 Q2	$6.11M	Sell	437,000 -47,800	-10%	-$668K	0.06%	106
2017 Q1	$6.65M	Sell	484,800 -272,565	-36%	-$3.74M	0.08%	107
2016 Q4	$5.43M	Hold	757,365	–	–	0.07%	107
2016 Q3	$11.5M	Hold	757,365	–	–	0.13%	93
2016 Q2	$7.46M	Hold	757,365	–	–	0.08%	99
2016 Q1	$10.1M	Buy	+757,365	New	+$10.1M	0.11%	93